A single-center clinical study on the combination of Five-flavor sophora flavescens enteric-coated capsules and vedolizumab in induction therapy for ulcerative colitis.

Although missing data were imputed, the differences still did not reach statistical significance ( Table 4 ).

also in 111,027 other papers

Although the combination group showed an apparent trend toward superiority over the monotherapy groups, not all differences reached statistical significance.

also in 709 other papers